High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction

Helison R. P. Carmo,Isabella Bonilha,Joaquim Barreto,Massimiliano Tognolini,Ilaria Zanotti,Andrei C. Sposito

DOI: https://doi.org/10.3390/ijms25021290

IF: 5.6

2024-01-20

International Journal of Molecular Sciences

Abstract:Despite significant therapeutic advancements, morbidity and mortality following myocardial infarction (MI) remain unacceptably high. This clinical challenge is primarily attributed to two significant factors: delayed reperfusion and the myocardial injury resulting from coronary reperfusion. Following reperfusion, there is a rapid intracellular pH shift, disruption of ionic balance, heightened oxidative stress, increased activity of proteolytic enzymes, initiation of inflammatory responses, and activation of several cell death pathways, encompassing apoptosis, necroptosis, and pyroptosis. The inflammatory cell death or pyroptosis encompasses the activation of the intracellular multiprotein complex known as the NLRP3 inflammasome. High-density lipoproteins (HDL) are endogenous particles whose components can either promote or mitigate the activation of the NLRP3 inflammasome. In this comprehensive review, we explore the role of inflammasome activation in the context of MI and provide a detailed analysis of how HDL can modulate this process.

biochemistry & molecular biology,chemistry, multidisciplinary